Avanos Medical Inc
NYSE:AVNS
Avanos Medical Inc
Research & Development
Avanos Medical Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avanos Medical Inc
NYSE:AVNS
|
Research & Development
-$27.2m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
Cooper Companies Inc
NYSE:COO
|
Research & Development
-$145.3m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Research & Development
-$180m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Research & Development
-$351.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-22%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Research & Development
-$95.2m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-16%
|
See Also
What is Avanos Medical Inc's Research & Development?
Research & Development
-27.2m
USD
Based on the financial report for Dec 31, 2023, Avanos Medical Inc's Research & Development amounts to -27.2m USD.
What is Avanos Medical Inc's Research & Development growth rate?
Research & Development CAGR 10Y
3%
Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Avanos Medical Inc have been 8% over the past three years , 8% over the past five years , and 3% over the past ten years .